Evidence map›Paper›PMID 33355191›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2021

Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.

Esther M John, Valerie McGuire, Allison W Kurian, Jocelyn Koo, Salma Shariff-Marco, Scarlett Lin Gomez, Iona Cheng, Theresa H M Keegan, Marilyn L Kwan, Leslie Bernstein and 2 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Pooled it
  2. Immigration and Social Factors, Tumor Stage, and Risk of Contralateral Breast Cancer in Asian American and Hispanic Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Esther M JohnDepartment of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, California. emjohn@stanford.edu.ORCID 0000-0003-3259-8003
Valerie McGuireDepartment of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, California.
Allison W KurianDepartment of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, California.
Jocelyn KooStanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
Salma Shariff-MarcoDepartment of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California.
Scarlett Lin GomezDepartment of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California.
Iona ChengDepartment of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California.
Theresa H M KeeganDivision of Hematology and Oncology, UC Davis Comprehensive Cancer Center, University of California, Davis, California.
Marilyn L KwanDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0001-8863-3950
Leslie BernsteinDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.ORCID 0000-0002-7692-6518
Cheryl VigenDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Anna H WuDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.

Funding

Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
Core-001U01CA164920 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Irene Andrulis, Sarah Violet Colonna · 2018 to 2026
$17.0M
Institutional Career Development CoreKL2TR001874 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GENKINGER, JEANINE M., SHIMBO, DAICHI · 2016 to 2025
$13.6M
MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCERR01CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1993 to 2002
$4.5M
Molecular Profiles and Lifestyle Factors in Breast Cancer PrognosisR01CA129059 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CAAN, BETTE J · 2009 to 2013
$3.6M
Research and Mentoring on Energetic Factors and Cancer: Established InvestigatorK05CA136967 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BERNSTEIN, LESLIE · 2009 to 2013
$684k
BREAST CANCER RISK FACTORS IN HISPANIC WOMENR01CA063446 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M · 1995 to 1998
–
NCATS NIH HHS KL2 TR001874NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS K05 CA136967NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA063446NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA129059NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA164920NCI NIH HHS U01 CA164973
6 · The paper itself

Abstract

backgroundLimited studies have investigated racial/ethnic survival disparities for breast cancer defined by estrogen receptor (ER) and progesterone receptor (PR) status in a multiethnic population.

methodsUsing multivariable Cox proportional hazards models, we assessed associations of race/ethnicity with ER/PR-specific breast cancer mortality in 10,366 California women diagnosed with breast cancer from 1993 to 2009. We evaluated joint associations of race/ethnicity, health care, sociodemographic, and lifestyle factors with mortality.

resultsAmong women with ER/PR

conclusionsRacial/ethnic survival disparities are more striking for ER/PR IMPACT: Addressing these factors may help reduce the higher mortality of African American women with ER/PR

Indexed as

AdultAgedBreast NeoplasmsCaliforniaCancer SurvivorsFemaleHumansMiddle AgedReceptors, EstrogenReceptors, ProgesteroneRegistriesSurvival AnalysisReceptors, EstrogenReceptors, Progesterone

Identifiers

PMID33355191
PMCPMC7867638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.